Betlife Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 58.14%
- Profit Growth 216.48%
- Ebitda 248.85%
- Net Worth 105.27%
- Total Assets 93.23%
About Betlife Formulations
Betlife Formulations Private Limited (BFPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 2016 (Eight years and nine months 1 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kathiravan Chinnusamy, Krishnamoorthy Kumar, and Shivaramakrishna Pulluri serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909TN2016PTC029548
-
Company No.
029548
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 May 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Betlife Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kathiravan Chinnusamy
|
Director | 13-Jan-2021 | Current |
|
Krishnamoorthy Kumar
|
Director | 13-Jan-2021 | Current |
|
Shivaramakrishna Pulluri
|
Director | 13-May-2016 | Current |
Financial Performance of Betlife Formulations.
Betlife Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 58.14% increase. The company also saw a substantial improvement in profitability, with a 216.48% increase in profit. The company's net worth Soared by an impressive increase of 105.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Betlife Formulations?
In 2020, Betlife Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Q Check Pharmaceuticals Private LimitedKathiravan Chinnusamy and Krishnamoorthy Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Betlife Formulations?
Betlife Formulations has a workforce of 13 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Betlife Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Betlife Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
